121 related articles for article (PubMed ID: 21782226)
21. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
[TBL] [Abstract][Full Text] [Related]
22. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy.
Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH
Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284
[TBL] [Abstract][Full Text] [Related]
23. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
24. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
[TBL] [Abstract][Full Text] [Related]
26. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY
J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
[TBL] [Abstract][Full Text] [Related]
27. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
[TBL] [Abstract][Full Text] [Related]
28. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
29. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.
Coleman RL; Keeney ED; Freedman RS; Burke TW; Eifel PJ; Rutledge FN
Gynecol Oncol; 1994 Oct; 55(1):29-35. PubMed ID: 7959262
[TBL] [Abstract][Full Text] [Related]
30. Treatment of cervical cancer with adjuvant chemotherapy versus adjuvant radiotherapy after radical hysterectomy and systematic lymphadenectomy.
Hosaka M; Watari H; Takeda M; Moriwaki M; Hara Y; Todo Y; Ebina Y; Sakuragi N
J Obstet Gynaecol Res; 2008 Aug; 34(4):552-6. PubMed ID: 18937708
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant pelvic irradiation in patients with node-negative carcinoma of the uterine cervix.
Uno T; Ito H; Yasuda S; Aruga T; Isobe K; Kawakami H; Mitsuhashi A; Tanaka N; Yamazawa K; Suzuka K; Sekiya S; Itami J; Shigematsu N; Kubo A
Anticancer Res; 2002; 22(2B):1213-6. PubMed ID: 12168928
[TBL] [Abstract][Full Text] [Related]
32. Post-hysterectomy radiotherapy in FIGO stage IB-IIB uterine cervical carcinoma.
Kim JH; Kim HJ; Hong S; Wu HG; Ha SW
Gynecol Oncol; 2005 Feb; 96(2):407-14. PubMed ID: 15661229
[TBL] [Abstract][Full Text] [Related]
33. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
34. Long term complications after radical hysterectomy with pelvic lymphadenectomy.
Manchana T; Sirisabya N; Lertkhachonsuk R; Worasethsin P; Khemapech N; Sittisomwong T; Vasuratna A; Termrungruanglert W; Tresukosol D
J Med Assoc Thai; 2009 Apr; 92(4):451-6. PubMed ID: 19374292
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
[TBL] [Abstract][Full Text] [Related]
36. [The value of adjuvant irradiation in lymphatic vessel invasion in patients with a cervical carcinoma in histopathological stage Ib and with negative lymph nodes].
Vavra N; Sevelda P; Seifert M; Timar J; Kudielka I; Kucera H
Strahlenther Onkol; 1992 Sep; 168(9):524-7. PubMed ID: 1411926
[TBL] [Abstract][Full Text] [Related]
37. Radical vaginal trachelectomy vs. radical hysterectomy for small early stage cervical cancer: a matched case-control study.
Beiner ME; Hauspy J; Rosen B; Murphy J; Laframboise S; Nofech-Mozes S; Ismiil N; Rasty G; Khalifa MA; Covens A
Gynecol Oncol; 2008 Aug; 110(2):168-71. PubMed ID: 18539313
[TBL] [Abstract][Full Text] [Related]
38. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
Kornovski Y; Gorchev G
J BUON; 2007; 12(1):57-63. PubMed ID: 17436403
[TBL] [Abstract][Full Text] [Related]
39. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
40. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
